Taro Pharmaceutical Industries Ltd.
Hedge Funds Holdings
Last updated:
Taro Pharmaceutical Industries Ltd.‘s stocks are currently a part of 40 hedge funds’ portfolios, which represents 5.86% of the total amount of its stocks outstanding. This makes up a total of 2.35M shares of Taro Pharmaceutical Industries Ltd.. Compared to the previous quarter, the number fell by -43.88% or -1.83M shares fewer. As for the holding position changes, 37.5% (15) of current hedge fund investors increased the number of shares held, 40% (16) of current holders sold a part of the shares held, and 7.5% (3) closed the holdings completely. 2 hedge funds are new holders of Taro Pharmaceutical Industries Ltd. stock in Q1 2023, it is 5% of total holders.
Hedge funds holding Taro Pharmaceutical Industries Ltd. (Q2 2018 – Q1 2023)
Q2 2018 | 106 |
---|---|
Q3 2018 | 111 |
Q4 2018 | 93 |
Q1 2019 | 102 |
Q2 2019 | 105 |
Q3 2019 | 101 |
Q4 2019 | 93 |
Q1 2020 | 88 |
Q2 2020 | 82 |
Q3 2020 | 78 |
Q4 2020 | 83 |
Q1 2021 | 79 |
Q2 2021 | 75 |
Q3 2021 | 69 |
Q4 2021 | 67 |
Q1 2022 | 61 |
Q2 2022 | 67 |
Q3 2022 | 62 |
Q4 2022 | 58 |
Q1 2023 | 40 |
Hedge funds changes in Taro Pharmaceutical Industries Ltd. positions (Q2 2018 – Q1 2023)
Q2 2018 | 15 | 26 | 44 | 15 | 6 |
---|---|---|---|---|---|
Q3 2018 | 21 | 32 | 31 | 16 | 11 |
Q4 2018 | 11 | 28 | 31 | 28 | -5 |
Q1 2019 | 19 | 29 | 35 | 11 | 8 |
Q2 2019 | 19 | 38 | 29 | 16 | 3 |
Q3 2019 | 12 | 36 | 27 | 13 | 13 |
Q4 2019 | 10 | 31 | 30 | 18 | 4 |
Q1 2020 | 13 | 24 | 30 | 17 | 4 |
Q2 2020 | 4 | 25 | 35 | 10 | 8 |
Q3 2020 | 6 | 28 | 25 | 10 | 9 |
Q4 2020 | 16 | 26 | 23 | 12 | 6 |
Q1 2021 | 10 | 24 | 24 | 13 | 8 |
Q2 2021 | 6 | 19 | 31 | 10 | 9 |
Q3 2021 | 6 | 26 | 18 | 11 | 8 |
Q4 2021 | 6 | 17 | 29 | 8 | 7 |
Q1 2022 | 4 | 20 | 26 | 8 | 3 |
Q2 2022 | 11 | 23 | 21 | 4 | 8 |
Q3 2022 | 5 | 19 | 24 | 10 | 4 |
Q4 2022 | 10 | 18 | 18 | 13 | -1 |
Q1 2023 | 2 | 15 | 16 | 3 | 4 |
Hedge funds changes in Taro Pharmaceutical Industries Ltd. stock options (Q2 2018 – Q1 2023)
Q2 2018 | 301,000 | 255,000 |
---|---|---|
Q3 2018 | 0 | 0 |
Q4 2018 | 0 | 0 |
Q1 2019 | 227,000 | 335,000 |
Q2 2019 | 0 | 0 |
Q3 2019 | 0 | 0 |
Q4 2019 | 0 | 0 |
Q1 2020 | 0 | 983,000 |
Q2 2020 | 0 | 1,137,000 |
Q3 2020 | 0 | 548,000 |
Q4 2020 | 0 | 184,000 |
Q1 2021 | 0 | 1,844,000 |
Q2 2021 | 0 | 0 |
Q3 2021 | 0 | 0 |
Q4 2021 | 0 | 0 |
Q1 2022 | 0 | 15,000 |
Q2 2022 | 0 | 7,000 |
Q3 2022 | 0 | 2,000 |
Q4 2022 | 0 | 0 |
Q1 2023 | 0 | 9,000 |